Tag
This article reviews clinical characteristics, onset timing, management, and outcomes of intraocular lens-associated UGH syndrome, highlighting challenges with late-onset disease and persistent ocular hypertension despite treatment.
Systemic nicotinamide supplementation is associated with reduced risk of POAG development in ocular hypertension, improved retinal function, and better quality of life, suggesting its neuroprotective potential as an adjunctive therapy in gl
New study reveals 26.5-37.5% of eyes with pseudoexfoliation syndrome develop glaucoma within 4 years, with ocular hypertension doubling risk. Standalone lens extraction reduced IOP by 3 mmHg.
Deep learning models predicting RNFL thickness from optic disc photographs can identify ocular hypertension patients at higher risk for primary open-angle glaucoma, enhancing early risk assessment and monitoring disease progression.
